Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS
NCT00334074
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Acute Myelogenous Leukemia
Myelodysplastic Syndromes
Chronic Myelogenous Leukemia
Interventions
DRUG:
Clofarabine and Cytarabine
Sponsor
Baylor Research Institute